tumors models, and response of tumors martin brown april 23, 2012
DESCRIPTION
Tumors Models, and Response of Tumors Martin Brown April 23, 2012. Cancers comprise more than tumor cells. Do the stromal cells affect the response to radiotherapy?. Hanahan and Weinberg, Cell 2011. Endothelial cells should be a prime target in radiotherapy – Julie Denekamp. Capillary. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/1.jpg)
Tumors Models, and
Response of Tumors
Martin BrownApril 23, 2012
![Page 2: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/2.jpg)
Hanahan and Weinberg, Cell 2011
Cancers comprise more than tumor cells. Do the stromal cells affect the response to radiotherapy?
![Page 3: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/3.jpg)
Capillary
Endothelial cell
Endothelial cells should be a prime target in radiotherapy – Julie Denekamp
•Endothelial cells in tumors are rapidly dividing so will die rapidly after irradiation
•One endothelial cell supports 2000 tumor cells!
![Page 4: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/4.jpg)
Tumor curability by IR does not depend on the sensitivity of the host (Budach et al, 1993)
![Page 5: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/5.jpg)
![Page 6: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/6.jpg)
TD50 assay for in vivo response of tumors
(Hewitt and Wilson, 1959)
![Page 7: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/7.jpg)
Cell survival curve of leukemia cells irradiated in situ and in vitro (Hewitt & Wilson,1959)
![Page 8: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/8.jpg)
Lung colony assay (Hill and Bush)
![Page 9: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/9.jpg)
Tumor Growth Delay Assay
![Page 10: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/10.jpg)
Tumor growth delay following different radiation doses.
![Page 11: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/11.jpg)
Demonstration of Tumor Radiosensitization using TCD50 assay (Sheldon et al, 1974)
![Page 12: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/12.jpg)
In vivo/in vitro (excision) assay
This is the fastest, cheapest and most accurate assay of the response of the tumor cells. However, it makes the assumption that the response of the cells is not altered by taking them out of the tumor.
![Page 13: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/13.jpg)
Demonstration of “hypoxic fraction” in mouse tumors (Rockwell & Kallman, 1972)
![Page 14: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/14.jpg)
Spheroids: an in vitro tumor model.
Mimics several aspects of tumors
-chronic hypoxia adjacent to necrosis
-non dividing cells
-cell to cell contact
-limited diffusion of drugs
![Page 15: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/15.jpg)
Tumor Hypoxia results from Differences in the Vasculature between Tumor and Normal Tissues
![Page 16: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/16.jpg)
Blood vessels Necrosis
HIF-1 staining
Chronic Hypoxia (HIF-1 staining) in Human Head & Neck Cancers(Aebersold et al,
2001)
![Page 17: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/17.jpg)
Oxygenation of human tumors is usually measured with an oxygen electrode (“Eppendorf”)
![Page 18: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/18.jpg)
Oxygen tensions of Normal Tissue and Nodes of Head and Neck Cancers
0
4
8
12
16
20
1000 10 20 30 40 50 60 70 80 90
0
4
8
12
16
20
0 10 20 30 40 50 60 70 80 90 100
Oxygen Partial Pressure (mm Hg)% o
f M
easu
rem
en
ts
Normal Subcutaneous Tissue
Tumor
Median pO2
![Page 19: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/19.jpg)
0.0
0.1
0.2
0.3
10 20 30 40 50 60 700 80
Median pO2 (mmHg)
Median pO2 Values for Tumor and Normal Tissues for 62 Head & Neck Cancer Patients (Le et al 2004)
Median pO2 values for Tumor and Normal
Proportionof
Values
Tumor Median= 11.8 mmHg
Normal Median= 51.9 mmHg
![Page 20: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/20.jpg)
Effect of Tumor Hypoxia on Local Control of Head and Neck Cancer (Brizel et al, 1999)
63 patients treated.Similar differencesfor survival and DFS.
![Page 21: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/21.jpg)
Oxygenation of Prostate Carcinoma by Eppendorf Electrode
Movsas et al, 2001 Parker et al, 2004
Med = 2.4mmHg Med = 4.5 mmHg
![Page 22: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/22.jpg)
Effect of tumor hypoxia on outcome of prostate ca to RT (Movsas et al, 2002)
pO2 = 5.3 mmHg
pO2 = 1.0 mmHg
Biochemical failure by PSA
![Page 23: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/23.jpg)
Median Oxygen Levels of Human Tumors
(Brown & Wilson Nat. Rev. Cancer 4: 437 2004)
![Page 24: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/24.jpg)
0.1 1 10 1001.0
1.5
2.0
2.5
3.0
OE
R(p
)
Oxygen Partial Pressure (p) (mm Hg)
It is incorrect to think that tumors are composed of hypoxic and aerobic cells. In fact
the majority are at intermediate pO2
Koch et al,1984
Whillans and Hunt,1982
Hypoxic AerobicIntermediate
![Page 25: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/25.jpg)
0 10 20 30 40 50 60-10
-9
-8
-7
-6
-5
-4
-3
-2
-1
10
10
10
10
10
10
10
10
10
10
100
No Hypoxic Cells
Sur
vivi
ng F
ract
ion
Total Dose (2 Gy Fractions)
10% hypoxic cells with full reoxygenation (binary)
10% hypoxic cells with no
reoxygenation
When the cells at intermediate hypoxia are considered the predicted survival to 2 Gy
fractions is dramatically altered
10% hypoxic cells and intermediate p02 cells with full reoxygenation
Wouters and Brown,1997
![Page 26: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/26.jpg)
Consequences of Tumor Hypoxia for Cancer Treatment
• Hypoxic cells are resistant to killing by IR
– Extent of hypoxia affects response to radiotherapy
• Hypoxia is associated with slowing of proliferation:
– Leads to resistance to most anticancer drugs.
• Hypoxia promotes and selects for a more malignant phenotype
– Hypoxic tumors are more metastatic
![Page 27: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/27.jpg)
Green: hypoxiaRed: proliferation (IdUrd+)
Hypoxia and proliferation in human H & N tumors (Van der Kogel et al)
![Page 28: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/28.jpg)
Human Glioblastoma Stained with EF5 (Red) and Ki-67 (Green) (Evans and Koch,
2002)
![Page 29: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/29.jpg)
Capillary
Distance from Capillary (µm)
Su
rviv
ing
Fra
ctio
n
O2 O2
150100500
. Radiation / Chem. DrugO2
Expect gradient of cell killing from blood vessels to necrosis
![Page 30: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/30.jpg)
X-ray Survival of Cells in SiHa Tumors as a function of Distance from Blood Vessels
(Durand & Olive, 1997)
HypoxicAerobic
![Page 31: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/31.jpg)
Expression of hypoxia induced proteins (eg CA IX) can be used in archival tissues as a surrogate for hypoxia.
Head and Neck
BreastAdenocarcinoma
Ovarian Adenocarcinoma
Immunohistochemical staining for CA IX
Wykoff et al, 2000
Hui et al, 2002
NPC
![Page 32: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/32.jpg)
Can we exploit tumor hypoxia?
• A drug specifically toxic to hypoxic cells
would kill only tumor cells - and the
most resistant ones.
![Page 33: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/33.jpg)
0 1000 2000 3000 4010 -5
10 -4
10 -3
10 -2
10 -1
100
TPZ Conc (µM)
Hypoxia
Air
00
Preferential Toxicity of Tirapazamine (TPZ) to Hypoxic Cells in vitro
Mouse SCCVII cells 1 hr exposure
100 101 102 103 10410-5
10-4
10-3
10-2
10-1
100
TPZ Conc (µM)
HCR=300
Su
rviv
ing
Fra
ctio
n
Mouse SCCVII cells 1 hr exposure
2
O
NN
N NH
O
TPZ
![Page 34: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/34.jpg)
Capillary
Distance from Capillary (µm)
Su
rviv
ing
Fra
cti
on
O2 O2
Addition of a Hypoxic Cytotoxin to Standard Treatment Could Exploit Tumor Hypoxia
Combined
Hypoxic Cytotoxin
150100500
. Radiation / Chem. DrugO2
![Page 35: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/35.jpg)
Complementary Killing by TPZ and IR in SiHa Tumors as a function of Distance from Blood
Vessels
(Durand & Olive, 1997)
HypoxicAerobic
Combined
![Page 36: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/36.jpg)
Primary site failure in 92 randomized advanced H&N patients (Peters et al,2007,)
PET hypoxia status
Treatment
P-valueRT + cis /no TPZ
RT + cis/TPZ
Non-Hypoxic
2/27 (7%) 3/21 (14%) NS
Hypoxic 8/18 (44%) 0/26 (0%) 0.0002
P-value 0.008 NS
![Page 37: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/37.jpg)
Results of multicenter randomized clinical trial of TPZ with advanced H & N cancer
693 patients without major protocol violationsAll 863 patients in 89 sites in 16 countries
Rischin et al and Peters et al, JCO, 2010
Need to select hypoxic tumors in future trials and have good QA for radiotherapy
![Page 38: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/38.jpg)
100806040200
100
1000
10000
90% probability80% probability
% Patients with Hypoxic Tumors
Number of
Patients
Patient Numbers Needed to Detect a Change from 40 to 65% Response
Rates
![Page 39: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/39.jpg)
SN30000 is superior to TPZ in multiple tumor models
Single doses ( 15 or 20 Gy) Fractionated 8 x 2 Gy SiHa tumor
Hicks et al, Clin Cancer Res 2010
![Page 40: Tumors Models, and Response of Tumors Martin Brown April 23, 2012](https://reader035.vdocuments.us/reader035/viewer/2022070416/568151e8550346895dc02272/html5/thumbnails/40.jpg)
Summary
• Sensitivity of tumor and normal cells can be assayed quantitatively in situ in experimental systems.
• Tumor hypoxia has a major negative impact on the curability of tumors by radiotherapy, and probably also chemotherapy
• Tumor hypoxia can be exploited using drugs specifically toxic to hypoxic cells.